• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

表没食子儿茶素没食子酸酯作为一种针对多巴胺 D₃/D₄ 受体的神经退行性疾病的潜在治疗药物。

Eckol as a Potential Therapeutic against Neurodegenerative Diseases Targeting Dopamine D₃/D₄ Receptors.

机构信息

Department of Food and Life Science, Pukyong National University, Busan 48513, Korea.

Department of Physics, Pukyong National University, Busan 48513, Korea.

出版信息

Mar Drugs. 2019 Feb 10;17(2):108. doi: 10.3390/md17020108.

DOI:10.3390/md17020108
PMID:30744179
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6409773/
Abstract

The G protein-coupled receptor (GPCR) family of proteins comprises signaling proteins that mediate cellular responses to various hormones and neurotransmitters, and serves as a prime target for drug discovery. Towards our goal of discovering secondary metabolites from natural sources that can function as neuronal drugs, we evaluated the modulatory effect of eckol on various GPCRs via cell-based functional assays. In addition, we conducted in silico predictions to obtain molecular insights into the functional effects of eckol. Functional assays revealed that eckol had a concentration-dependent agonist effect on dopamine D₃ and D₄ receptors. The half maximal effective concentration (EC) of eckol for the dopamine D₃ and D₄ receptors was 48.62 ± 3.21 and 42.55 ± 2.54 µM, respectively, while the EC values of dopamine as a reference agonist for these two receptors were 2.9 and 3.3 nM, respectively. In silico studies revealed that a low binding energy in addition to hydrophilic, hydrophobic, π⁻alkyl, and π⁻π T-shaped interactions are potential mechanisms by which eckol binds to the dopamine receptors to exert its agonist effects. Molecular dynamics (MD) simulation revealed that Phe346 of the dopamine receptors is important for binding of eckol, similar to eticlopride and dopamine. Our results collectively suggest that eckol is a potential D₃/D₄ agonist for the management of neurodegenerative diseases, such as Parkinson's disease.

摘要

G 蛋白偶联受体(GPCR)家族蛋白包含信号蛋白,这些信号蛋白介导细胞对各种激素和神经递质的反应,是药物发现的主要靶点。为了从天然来源中发现可作为神经药物的次级代谢产物,我们通过基于细胞的功能测定评估了表儿茶素对各种 GPCR 的调节作用。此外,我们还进行了计算预测,以获得表儿茶素对功能影响的分子见解。功能测定表明,表儿茶素有浓度依赖性激动剂作用于多巴胺 D₃ 和 D₄ 受体。表儿茶素对多巴胺 D₃ 和 D₄ 受体的半数最大有效浓度(EC₅₀)分别为 48.62 ± 3.21 和 42.55 ± 2.54 µM,而多巴胺作为这两种受体的参考激动剂的 EC 值分别为 2.9 和 3.3 nM。计算研究表明,低结合能以及亲水性、疏水性、π⁻烷基和 π⁻π T 型相互作用是表儿茶素结合多巴胺受体发挥激动作用的潜在机制。分子动力学(MD)模拟表明,多巴胺受体的 Phe346 对表儿茶素的结合很重要,类似于埃替克洛平和多巴胺。我们的研究结果表明,表儿茶素可能是一种潜在的 D₃/D₄ 激动剂,可用于治疗神经退行性疾病,如帕金森病。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8012/6409773/74504b05e187/marinedrugs-17-00108-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8012/6409773/2c31a47a9ad5/marinedrugs-17-00108-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8012/6409773/b6bdaf69d109/marinedrugs-17-00108-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8012/6409773/7e3d1358aba5/marinedrugs-17-00108-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8012/6409773/c763e83fb3f6/marinedrugs-17-00108-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8012/6409773/ee60b31fa7b5/marinedrugs-17-00108-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8012/6409773/74504b05e187/marinedrugs-17-00108-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8012/6409773/2c31a47a9ad5/marinedrugs-17-00108-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8012/6409773/b6bdaf69d109/marinedrugs-17-00108-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8012/6409773/7e3d1358aba5/marinedrugs-17-00108-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8012/6409773/c763e83fb3f6/marinedrugs-17-00108-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8012/6409773/ee60b31fa7b5/marinedrugs-17-00108-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8012/6409773/74504b05e187/marinedrugs-17-00108-g006.jpg

相似文献

1
Eckol as a Potential Therapeutic against Neurodegenerative Diseases Targeting Dopamine D₃/D₄ Receptors.表没食子儿茶素没食子酸酯作为一种针对多巴胺 D₃/D₄ 受体的神经退行性疾病的潜在治疗药物。
Mar Drugs. 2019 Feb 10;17(2):108. doi: 10.3390/md17020108.
2
Characterizing fucoxanthin as a selective dopamine D/D receptor agonist: Relevance to Parkinson's disease.将岩藻黄质描述为一种选择性多巴胺 D/D 受体激动剂:与帕金森病的相关性。
Chem Biol Interact. 2019 Sep 1;310:108757. doi: 10.1016/j.cbi.2019.108757. Epub 2019 Jul 16.
3
Probing Multi-Target Action of Phlorotannins as New Monoamine Oxidase Inhibitors and Dopaminergic Receptor Modulators with the Potential for Treatment of Neuronal Disorders.探讨岩藻黄质作为新型单胺氧化酶抑制剂和多巴胺能受体调节剂的多靶点作用及其在治疗神经障碍方面的潜力。
Mar Drugs. 2019 Jun 24;17(6):377. doi: 10.3390/md17060377.
4
In vitro characterization of SLV308 (7-[4-methyl-1-piperazinyl]-2(3H)-benzoxazolone, monohydrochloride): a novel partial dopamine D2 and D3 receptor agonist and serotonin 5-HT1A receptor agonist.SLV308(7-[4-甲基-1-哌嗪基]-2(3H)-苯并恶唑酮,盐酸盐)的体外特性:一种新型的多巴胺D2和D3受体部分激动剂及5-羟色胺5-HT1A受体激动剂
Synapse. 2006 Dec 15;60(8):599-608. doi: 10.1002/syn.20330.
5
Recent advances in the search for D3- and D4-selective drugs: probes, models and candidates.近期在寻找 D3 和 D4 选择性药物方面的进展:探针、模型和候选药物。
Trends Pharmacol Sci. 2011 Mar;32(3):148-57. doi: 10.1016/j.tips.2010.12.003. Epub 2011 Jan 12.
6
Multi-target dopamine D3 receptor modulators: Actionable knowledge for drug design from molecular dynamics and machine learning.多靶点多巴胺 D3 受体调节剂:来自分子动力学和机器学习的药物设计可操作知识。
Eur J Med Chem. 2020 Feb 15;188:111975. doi: 10.1016/j.ejmech.2019.111975. Epub 2019 Dec 23.
7
Synthesis, pharmacological evaluation and molecular modeling studies of triazole containing dopamine D3 receptor ligands.含三唑的多巴胺D3受体配体的合成、药理学评价及分子模拟研究
Bioorg Med Chem Lett. 2015 Feb 1;25(3):519-23. doi: 10.1016/j.bmcl.2014.12.023. Epub 2014 Dec 17.
8
Dopamine D3 receptor antagonist reveals a cryptic pocket in aminergic GPCRs.多巴胺 D3 受体拮抗剂揭示了胺能 GPCR 中的一个隐匿口袋。
Sci Rep. 2018 Jan 17;8(1):897. doi: 10.1038/s41598-018-19345-7.
9
Penile erection and yawning induced by dopamine D2-like receptor agonists in rats: influence of strain and contribution of dopamine D2, but not D3 and D4 receptors.大鼠中多巴胺D2样受体激动剂诱导的阴茎勃起和打哈欠:品系的影响以及多巴胺D2受体而非D3和D4受体的作用
Behav Pharmacol. 2009 Jul;20(4):303-11. doi: 10.1097/FBP.0b013e32832ec5aa.
10
Cariprazine (RGH-188), a dopamine D(3) receptor-preferring, D(3)/D(2) dopamine receptor antagonist-partial agonist antipsychotic candidate: in vitro and neurochemical profile.卡利拉嗪(RGH-188),一种多巴胺 D3 受体优先结合的、D3/D2 多巴胺受体拮抗剂-部分激动剂抗精神病候选药物:体外和神经化学特征。
J Pharmacol Exp Ther. 2010 Apr;333(1):328-40. doi: 10.1124/jpet.109.160432. Epub 2010 Jan 21.

引用本文的文献

1
Marine Pharmacology in 2019-2021: Marine Compounds with Antibacterial, Antidiabetic, Antifungal, Anti-Inflammatory, Antiprotozoal, Antituberculosis and Antiviral Activities; Affecting the Immune and Nervous Systems, and Other Miscellaneous Mechanisms of Action.2019-2021 年海洋药理学:具有抗菌、抗糖尿病、抗真菌、抗炎、抗原生动物、抗结核和抗病毒活性的海洋化合物;影响免疫系统和神经系统以及其他各种作用机制。
Mar Drugs. 2024 Jun 30;22(7):309. doi: 10.3390/md22070309.
2
The Neuropharmacological Evaluation of Seaweed: A Potential Therapeutic Source.海藻的神经药理学评价:一种潜在的治疗来源。
Cells. 2023 Nov 18;12(22):2652. doi: 10.3390/cells12222652.
3

本文引用的文献

1
Pharmacogenomics of GPCR Drug Targets.GPCR 药物靶点的药物基因组学。
Cell. 2018 Jan 11;172(1-2):41-54.e19. doi: 10.1016/j.cell.2017.11.033. Epub 2017 Dec 14.
2
Phlorotannins of the edible brown seaweed Ecklonia cava Kjellman induce sleep via positive allosteric modulation of gamma-aminobutyric acid type A-benzodiazepine receptor: A novel neurological activity of seaweed polyphenols.可食用褐藻海蕴中的间苯三酚单宁通过对γ-氨基丁酸A型-苯二氮䓬受体的正变构调节诱导睡眠:海藻多酚的一种新神经学活性。
Food Chem. 2012 Jun 1;132(3):1133-1142. doi: 10.1016/j.foodchem.2011.08.040. Epub 2011 Aug 23.
3
Trends in GPCR drug discovery: new agents, targets and indications.
In Vitro Human Monoamine Oxidase Inhibition and Human Dopamine D Receptor Antagonist Effect of Natural Flavonoids for Neuroprotection.
天然类黄酮的体外人单胺氧化酶抑制作用和人多巴胺 D 受体拮抗作用的神经保护作用。
Int J Mol Sci. 2023 Nov 1;24(21):15859. doi: 10.3390/ijms242115859.
4
Future Directions for Developing Non-dopaminergic Strategies for the Treatment of Parkinson's Disease.开发治疗帕金森病非多巴胺能策略的未来方向
Curr Neuropharmacol. 2024;22(10):1606-1620. doi: 10.2174/1570159X21666230731110709.
5
Therapeutic effects of phlorotannins in the treatment of neurodegenerative disorders.褐藻多酚在神经退行性疾病治疗中的疗效。
Front Mol Neurosci. 2023 May 18;16:1193590. doi: 10.3389/fnmol.2023.1193590. eCollection 2023.
6
A Bioactive Substance Derived from Brown Seaweeds: Phlorotannins.一种源自褐藻的生物活性物质:岩藻黄质。
Mar Drugs. 2022 Nov 26;20(12):742. doi: 10.3390/md20120742.
7
In Vitro and In Silico Characterization of G-Protein Coupled Receptor (GPCR) Targets of Phlorofucofuroeckol-A and Dieckol.Phlorofucofuroeckol-A 和 Dieckol 作用的 G 蛋白偶联受体 (GPCR) 靶点的体外和计算研究
Mar Drugs. 2021 Jun 4;19(6):326. doi: 10.3390/md19060326.
8
Marine algal antagonists targeting 3CL protease and spike glycoprotein of SARS-CoV-2: a computational approach for anti-COVID-19 drug discovery.海洋藻类化合物 3CL 蛋白酶和 SARS-CoV-2 刺突糖蛋白靶点:抗 COVID-19 药物发现的计算方法。
J Biomol Struct Dyn. 2022;40(19):8961-8988. doi: 10.1080/07391102.2021.1921032. Epub 2021 May 20.
9
Recent Developments in New Therapeutic Agents against Alzheimer and Parkinson Diseases: In-Silico Approaches.新型阿尔茨海默病和帕金森病治疗药物的最新进展:计算机模拟方法。
Molecules. 2021 Apr 11;26(8):2193. doi: 10.3390/molecules26082193.
10
Neuroprotective Effect of Aurantio-Obtusin, a Putative Vasopressin V Receptor Antagonist, on Transient Forebrain Ischemia Mice Model.橙酮-obtusin 对短暂性前脑缺血小鼠模型的神经保护作用,一种潜在的血管加压素 V 受体拮抗剂。
Int J Mol Sci. 2021 Mar 24;22(7):3335. doi: 10.3390/ijms22073335.
G蛋白偶联受体(GPCR)药物研发趋势:新药物、靶点与适应症
Nat Rev Drug Discov. 2017 Dec;16(12):829-842. doi: 10.1038/nrd.2017.178. Epub 2017 Oct 27.
4
D dopamine receptor high-resolution structures enable the discovery of selective agonists.D 多巴胺受体的高分辨率结构有助于发现选择性激动剂。
Science. 2017 Oct 20;358(6361):381-386. doi: 10.1126/science.aan5468.
5
Investigation of naphthofuran moiety as potential dual inhibitor against BACE-1 and GSK-3β: molecular dynamics simulations, binding energy, and network analysis to identify first-in-class dual inhibitors against Alzheimer's disease.萘并呋喃部分作为抗β-分泌酶1(BACE-1)和糖原合成酶激酶-3β(GSK-3β)潜在双重抑制剂的研究:分子动力学模拟、结合能及网络分析以鉴定针对阿尔茨海默病的新型双重抑制剂
J Mol Model. 2017 Aug;23(8):239. doi: 10.1007/s00894-017-3396-7. Epub 2017 Jul 24.
6
Evaluation of the inhibitory effects of eckol and dieckol isolated from edible brown alga Eisenia bicyclis on human monoamine oxidases A and B.对从可食用褐藻海带中分离出的eckol和dieckol对人单胺氧化酶A和B的抑制作用的评估。
Arch Pharm Res. 2017 Apr;40(4):480-491. doi: 10.1007/s12272-017-0904-3. Epub 2017 Mar 1.
7
p38 MAPK and PI3K/AKT Signalling Cascades inParkinson's Disease.帕金森病中的p38丝裂原活化蛋白激酶和磷脂酰肌醇-3激酶/蛋白激酶B信号级联反应
Int J Mol Cell Med. 2015 Spring;4(2):67-86.
8
Regulation of neuronal communication by G protein-coupled receptors.G蛋白偶联受体对神经元通讯的调节
FEBS Lett. 2015 Jun 22;589(14):1607-19. doi: 10.1016/j.febslet.2015.05.007. Epub 2015 May 14.
9
Anti-inflammatory activity of edible brown alga Eisenia bicyclis and its constituents fucosterol and phlorotannins in LPS-stimulated RAW264.7 macrophages.食用褐藻鹅肠菜及其成分岩藻甾醇和多酚在 LPS 刺激的 RAW264.7 巨噬细胞中的抗炎活性。
Food Chem Toxicol. 2013 Sep;59:199-206. doi: 10.1016/j.fct.2013.05.061. Epub 2013 Jun 14.
10
Neuroprotective effect of edible brown alga Eisenia bicyclis on amyloid beta peptide-induced toxicity in PC12 cells.食用褐藻鹿角菜对淀粉样β肽诱导的 PC12 细胞毒性的神经保护作用。
Arch Pharm Res. 2012 Nov;35(11):1989-98. doi: 10.1007/s12272-012-1116-5. Epub 2012 Dec 4.